ARCHIVES

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Wender Named ACS Chief Cancer Control Officer

August 9, 2013

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

Payline For 1988 Would Be Around 160 With President’s Budget

January 16, 1987

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

Funding Opportunities: AACR Accepting Submissions for Two Dream Team Grants

September 19, 2014